The U.S. Supreme Court Denies Patent on Naturally Occurring Genes

The U. S. Supreme Court this week unanimously denied a biotechnology firm the legal right to patent human genes isolated from a patient’s blood stream. The court ruled that because the genes at issue were naturally occurring, they were not patentable. Synthetic DNA strands, the court observed, would be patentable.

Leave a Reply

Your email address will not be published. Required fields are marked *